Exelon and B12 drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Exelon (rivastigmine tartrate) and B12 (cobalamin). Common drug interactions include chronic obstructive pulmonary disease among females and hypotension among males.

The phase IV clinical study analyzes what interactions people have when they take Exelon and B12. It is created by eHealthMe based on reports of 49 people who take the same drugs from the FDA, and is updated regularly.

What is Exelon?

Exelon has active ingredients of rivastigmine tartrate. It is often used in alzheimer's disease. eHealthMe is studying from 11,060 Exelon users. Check the latest studies of Exelon.

What is B12?

B12 has active ingredients of cobalamin. It is often used in vitamin b12 deficiency. eHealthMe is studying from 121,894 B12 users. Check the latest studies of B12.

On Jul, 18, 2026

49 people who take Exelon and B12 together, and have interactions are studied.

What are the common drug interactions of Exelon and B12, by gender? *:

female:

Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Cough
Dehydration (dryness resulting from the removal of water)
Dizziness
Nausea (feeling of having an urge to vomit)
Anger
Ataxia (loss of full control of bodily movements)
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Confusional state
Crying

male:

Hypotension (abnormally low blood pressure)
Fall
Aggression
Anaphylactic reaction (serious allergic reaction)
Anxiety
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Blood pressure diastolic increased
Blood pressure systolic increased
Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
Disturbance in attention

What are the common drug interactions of Exelon and B12, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Asthenia (weakness)
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Cough
Dizziness
Hypertension (high blood pressure)
Infection
Interstitial lung disease
Muscular weakness (muscle weakness)
Nasopharyngitis (inflammation of the nasopharynx)

40-49:

n/a

50-59:

Pain in extremity
Pulmonary embolism (blockage of the main artery of the lung)
Respiratory tract congestion (blockage on respiratory system)
Wheezing (a high-pitched whistling sound made while you breath)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
Cough
Dehydration (dryness resulting from the removal of water)
Fall
Local swelling (swelling at the site of some application of substance or injury)

60+:

Hallucination (an experience involving the perception of something not present)
Anaemia (lack of blood)
C-reactive protein increased
Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
Disturbance in attention
Drug ineffective
Haematocrit decreased
Activated partial thromboplastin time prolonged
Anaphylactic reaction (serious allergic reaction)
Anger

What are the existing conditions these people have? *

Parkinson's Disease: 17 people, 34.69%
Multiple Myeloma (cancer of the plasma cells): 6 people, 12.24%
Hallucinations (sensations that appear real but are created by your mind): 4 people, 8.16%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 6.12%
Pain: 3 people, 6.12%
Nausea (feeling of having an urge to vomit): 3 people, 6.12%
Diabetes: 3 people, 6.12%
Depression: 3 people, 6.12%
Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 3 people, 6.12%

* Approximation only. Some reports may have incomplete information.

Do you take Exelon and B12?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously